CIK: 0001974915
Total reported value
$3.6B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | Stock-Other | 8.71% | -4.04% | +90.00% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 7.31% | -7.31% | EXIT | |
| 3 | ACLXGBX | Arcellx INC | Stock-Other | 6.48% | -6.48% | EXIT | |
| 4 | 430 | Terns Pharmaceuticals INC | Stock-Other | 6.18% | -4.71% | — | |
| 5 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 6.06% | -0.41% | +261.45% | |
| 6 | GMED | Globus Medical INC - A | Stock-Healthcare | 3.78% | -2.31% | +2.00% | |
| 7 | NRIX | Nurix Therapeutics INC | Stock-Other | 3.02% | — | +34.96% | |
| 8 | ALC | Alcon Inc. | Stock-Healthcare | 2.96% | -1.27% | +0.45% | |
| 9 | DXCM | Dexcom INC | Stock-Healthcare | 2.88% | -2.88% | EXIT | |
| 10 | MRK | Merck & Co. INC. | Stock-Healthcare | 2.77% | -2.77% | EXIT | |
| 11 | TSHA | Taysha Gene Therapies INC | Stock-Other | 2.57% | — | +150.00% | |
| 12 | ABT | Abbott Laboratories | Stock-Healthcare | 2.56% | -2.56% | EXIT | |
| 13 | ✓ | Immatics NV | Stock-Other | 2.19% | — | -3.54% | |
| 14 | TYRA | Tyra Biosciences INC | Stock-Other | 2.17% | -2.11% | — | |
| 15 | BCAX | Bicara Therapeutics INC | Stock-Other | 2.05% | +0.97% | -29.90% | |
| 16 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 2.03% | +1.96% | — | |
| 17 | ELVN | Enliven Therapeutics INC | Stock-Other | 2.01% | +1.55% | +230.17% | |
| 18 | IRON | Disc Medicine INC | Stock-Other | 1.98% | — | +47.00% | |
| 19 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.68% | -1.68% | EXIT | |
| 20 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 1.65% | -1.65% | EXIT | |
| 21 | LXEO | Lexeo Therapeutics INC | Stock-Other | 1.51% | — | +37.69% | |
| 22 | ANRO | Alto Neuroscience INC | Stock-Other | 1.50% | — | +161.58% | |
| 23 | APGE | Apogee Therapeutics INC | Stock-Other | 1.41% | +1.18% | +29.41% | |
| 24 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 1.40% | -1.22% | — | |
| 25 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 1.30% | -1.30% | EXIT | |
| 26 | ASND | Ascendis Pharma A/S | Stock-Other | 1.27% | +1.13% | -70.83% | |
| 27 | RAPP | Rapport Therapeutics INC | Stock-Other | 1.14% | — | +16.84% | |
| 28 | SLDB | Solid Biosciences INC | Stock-Other | 1.12% | — | +95.46% | |
| 29 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.08% | — | -3.32% | |
| 30 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.05% | +0.77% | -53.33% | |
| 31 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.04% | — | +152.00% | |
| 32 | VERA | Vera Therapeutics INC | Stock-Other | 0.95% | +0.59% | -27.63% | |
| 33 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.91% | — | -45.45% | |
| 34 | LNTH | Lantheus Holdings INC | Stock-Healthcare | 0.81% | -0.81% | EXIT | |
| 35 | RVMD | Revolution Medicines INC | Stock-Healthcare | 0.80% | +5.66% | -53.17% | |
| 36 | ZYME | Zymeworks INC | Stock-Other | 0.77% | -0.77% | EXIT | |
| 37 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.69% | +1.64% | — | |
| 38 | UPB | Upstream Bio INC | Stock-Other | 0.66% | -0.66% | EXIT | |
| 39 | BBNX | Beta Bionics INC | Stock-Other | 0.62% | — | — | |
| 40 | ✓ | Crescent Biopharma INC. | Stock-Other | 0.60% | — | — | |
| 41 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 0.60% | +1.27% | — | |
| 42 | PEN | Penumbra INC | Stock-Healthcare | 0.53% | — | — | |
| 43 | GERN | Geron CORP | Stock-Other | 0.51% | — | -34.28% | |
| 44 | RGEN | Repligen CORP | Stock-Healthcare | 0.46% | +2.59% | -79.25% | |
| 45 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 0.46% | — | — | |
| 46 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.46% | +1.24% | — | |
| 47 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.41% | +1.25% | -3.13% | |
| 48 | FULC | Fulcrum Therapeutics INC | Stock-Other | 0.37% | — | — | |
| 49 | SVRA | Savara INC | Stock-Other | 0.33% | — | -60.00% | |
| 50 | ✓ | Engene Holdings INC | Stock-Other | 0.32% | — | +185.14% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | +4.9% | +90.00% | Add |
| 2 | BMRN | Biomarin Pharmaceutical INC | +4% | +261.45% | Add |
| 3 | ACLXGBX | Arcellx INC | +1.9% | +134.00% | Add |
| 4 | TSHA | Taysha Gene Therapies INC | +1.8% | +150.00% | Add |
| 5 | NRIX | Nurix Therapeutics INC | +1.6% | +34.96% | Add |
| 6 | ANRO | Alto Neuroscience INC | +1.3% | +161.58% | Add |
| 7 | ABT | Abbott Laboratories | +1.1% | +140.00% | Add |
| 8 | ELVN | Enliven Therapeutics INC | +0.9% | +230.17% | Add |
| 9 | DXCM | Dexcom INC | +0.9% | +96.15% | Add |
| 10 | DAWNGBX | Day One Biopharmaceuticals I | +0.8% | +94.39% | Add |
| 11 | APGE | Apogee Therapeutics INC | +0.7% | +29.41% | Add |
| 12 | TYRA | Tyra Biosciences INC | +0.6% | — | Unchanged |
| 13 | 4XC1 | Kalvista Pharmaceuticals INC | +0.6% | +152.00% | Add |
| 14 | GMED | Globus Medical INC - A | +0.6% | +2.00% | Add |
| 15 | LXEO | Lexeo Therapeutics INC | +0.5% | +37.69% | Add |
| 16 | IRON | Disc Medicine INC | +0.5% | +47.00% | Add |
| 17 | AXSM | Axsome Therapeutics INC | +0.5% | +40.00% | Add |
| 18 | LNTH | Lantheus Holdings INC | +0.4% | +111.76% | Add |
| 19 | SLDB | Solid Biosciences INC | +0.3% | +95.46% | Add |
| 20 | BDTX | Black Diamond Therapeutics I | -0.9% | -84.32% | Trim |
| 21 | XENE | Xenon Pharmaceuticals INC | -1.1% | -45.45% | Trim |
| 22 | JAZZ | Jazz Pharmaceuticals plc | -1.3% | -42.00% | Trim |
| 23 | SRRK | Scholar Rock Holding CORP | -1.5% | -53.33% | Trim |
| 24 | DYN | Dyne Therapeutics INC | -1.5% | -95.68% | Trim |
| 25 | BCAX | Bicara Therapeutics INC | -1.6% | -29.90% | Trim |
| 26 | RGEN | Repligen CORP | -2% | -79.25% | Trim |
| 27 | ASND | Ascendis Pharma A/S | -4.1% | -70.83% | Trim |
| 28 | NUVL | Nuvalent Inc-a | -4.1% | -95.82% | Trim |
| 29 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 30 | 430 | Terns Pharmaceuticals INC | — | NEW | New buy |
| 31 | MRK | Merck & Co. INC. | — | NEW | New buy |
| 32 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 33 | IONS | Ionis Pharmaceuticals INC | — | EXIT | Sold out |
| 34 | BDX | Becton Dickinson And Co | — | EXIT | Sold out |
| 35 | ARWR | Arrowhead Pharmaceuticals In | — | NEW | New buy |
| 36 | DNTH | Dianthus Therapeutics INC | — | EXIT | Sold out |
| 37 | OLMA | Olema Pharmaceuticals INC | — | NEW | New buy |
| 38 | CYTK | Cytokinetics INC | — | EXIT | Sold out |
| 39 | BIIB | Biogen INC | — | EXIT | Sold out |
| 40 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 41 | CATBUSD | Astria Therapeutics INC | — | EXIT | Sold out |
| 42 | CRNX | Crinetics Pharmaceuticals In | — | EXIT | Sold out |
| 43 | DHR | Danaher CORP | — | EXIT | Sold out |
| 44 | BLTE | Belite Bio INC - Adr | — | EXIT | Sold out |
| 45 | RARE | Ultragenyx Pharmaceutical In | — | EXIT | Sold out |
| 46 | IMCR | Immunocore Holdings Plc-adr | — | NEW | New buy |
| 47 | UPB | Upstream Bio INC | — | NEW | New buy |
| 48 | ✓ | Crescent Biopharma INC. | — | NEW | New buy |
| 49 | BCRX | Biocryst Pharmaceuticals INC | — | NEW | New buy |
| 50 | PEN | Penumbra INC | — | NEW | New buy |